Searched for
SUN PHARMA SHAREHOLDER VALUE
Eswari Global Metal Industries files papers for Rs 1,100-1,300-cr IPOEswari Global Metal Industries is poised for a major Initial Public Offering (IPO) with an ambitious target of raising Rs 1,100 to Rs 1,300...- Tata Motors-Iveco revenue to be $35-40 billion in 5 years: N ChandrasekaranTata Motors is projecting a remarkable revenue growth of $35-40 billion in its commercial vehicle sector over the next five years from its ...
- Astral shares drop 6% after demerger. What should investors do?Astral shares fell nearly 6% on Monday after the company’s board approved the demerger of its chemicals business into a newly incorporated ...
- Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
- Quote of the Day by Sun Tzu: "Place your army on death ground, and it will survive; plunge it into desperate straits, and it will..." — Ultimate life lessons on winning the war: The Art of War reveals why your greatest victories begin when retreat is impossibleQuote of the Day by Sun Tzu explores one of history's most enduring lessons on courage, commitment, and human psychology. In Chapter 11 of ...
- Beyond Valuations: Philip Fisher's timeless guide to quality stock investingLegendary investor Philip Fisher championed a qualitative approach to stock picking, emphasizing exceptional businesses with strong managem...
- Sebi seeks clarification from Jio Platforms on IPO filingIndia's capital markets regulator Sebi has requested clarifications from Jio Platforms regarding its draft IPO papers. This move signals a ...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- AI will amplify, not replace companies that adapt fast: Nandan NilekaniInfosys is aggressively pursuing the AI-first services market, projecting a $300-400 billion opportunity by 2030. Chairman Nandan Nilekani ...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Reliance, financials and defence top investment picks as market leadership broadens: Rahul ShahReliance Industries is poised for a turnaround, with strong earnings, a Jio Platforms IPO, and AI/energy investments promising significant ...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Bringing back open-market buybacks through stock exchanges is the right decisionSEBI’s decision to restore open-market buybacks through stock exchanges marks a pragmatic regulatory shift that supports efficient capital ...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Load More
